Ana Polo-López, Joaquín Calatayud, Laura López-Bueno, Rodrigo Núñez-Cortés, Lars Louis Andersen, Rubén López-Bueno
{"title":"家族史引导的身体活动预防心血管疾病。","authors":"Ana Polo-López, Joaquín Calatayud, Laura López-Bueno, Rodrigo Núñez-Cortés, Lars Louis Andersen, Rubén López-Bueno","doi":"10.1016/j.amepre.2025.108080","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>It remains unclear if individuals with a family history of cardiovascular disease (CVD) can achieve similar CVD incidence reductions through moderate-to-vigorous physical activity (MVPA) as those without a family history. The aim of the study was to investigate the importance of familial CVD history on the association of MVPA with CVD risk.</p><p><strong>Methods: </strong>A prospective cohort from the UK Biobank who completed one week of accelerometer-based MVPA measurements from June 1, 2013, to December 23, 2015 was analyzed. The exposures were the different doses of MVPA derived from accelerometry. The main outcomes and measures were the dose-response associations between moderate-to-vigorous MVPA and incident CVD in individuals with and without a family history of CVD.</p><p><strong>Results: </strong>74,715 individuals (mean age 55.2 years) were examined. The median follow-up time was 7.9 years. The dose-response association between MVPA and incident CVD among individuals with family history of CVD showed significant risk reductions within the range of 10-1,555 weekly minutes (reference: 0 MVPA minutes). The optimal risk reduction (i.e., nadir of the curve) was identified at 555 weekly minutes of MVPA (HR, 0.72 [95% CI, 0.64-0.81]). The dose-response associations between MVPA and incident CVD among individuals with no family history of CVD showed significant risk reductions within the range of 220-555 weekly minutes. The optimal risk reduction was identified at 445 weekly minutes of MVPA (HR, 0.80 [95% CI, 0.65-0.99]).</p><p><strong>Conclusions: </strong>Physical activity guidelines should account for familial CVD history, as those with a family history may achieve greater risk reductions.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":" ","pages":"108080"},"PeriodicalIF":4.5000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Family History-Guided Physical Activity for Cardiovascular Disease Prevention.\",\"authors\":\"Ana Polo-López, Joaquín Calatayud, Laura López-Bueno, Rodrigo Núñez-Cortés, Lars Louis Andersen, Rubén López-Bueno\",\"doi\":\"10.1016/j.amepre.2025.108080\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>It remains unclear if individuals with a family history of cardiovascular disease (CVD) can achieve similar CVD incidence reductions through moderate-to-vigorous physical activity (MVPA) as those without a family history. The aim of the study was to investigate the importance of familial CVD history on the association of MVPA with CVD risk.</p><p><strong>Methods: </strong>A prospective cohort from the UK Biobank who completed one week of accelerometer-based MVPA measurements from June 1, 2013, to December 23, 2015 was analyzed. The exposures were the different doses of MVPA derived from accelerometry. The main outcomes and measures were the dose-response associations between moderate-to-vigorous MVPA and incident CVD in individuals with and without a family history of CVD.</p><p><strong>Results: </strong>74,715 individuals (mean age 55.2 years) were examined. The median follow-up time was 7.9 years. The dose-response association between MVPA and incident CVD among individuals with family history of CVD showed significant risk reductions within the range of 10-1,555 weekly minutes (reference: 0 MVPA minutes). The optimal risk reduction (i.e., nadir of the curve) was identified at 555 weekly minutes of MVPA (HR, 0.72 [95% CI, 0.64-0.81]). The dose-response associations between MVPA and incident CVD among individuals with no family history of CVD showed significant risk reductions within the range of 220-555 weekly minutes. The optimal risk reduction was identified at 445 weekly minutes of MVPA (HR, 0.80 [95% CI, 0.65-0.99]).</p><p><strong>Conclusions: </strong>Physical activity guidelines should account for familial CVD history, as those with a family history may achieve greater risk reductions.</p>\",\"PeriodicalId\":50805,\"journal\":{\"name\":\"American Journal of Preventive Medicine\",\"volume\":\" \",\"pages\":\"108080\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-09-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Preventive Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.amepre.2025.108080\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Preventive Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.amepre.2025.108080","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Family History-Guided Physical Activity for Cardiovascular Disease Prevention.
Introduction: It remains unclear if individuals with a family history of cardiovascular disease (CVD) can achieve similar CVD incidence reductions through moderate-to-vigorous physical activity (MVPA) as those without a family history. The aim of the study was to investigate the importance of familial CVD history on the association of MVPA with CVD risk.
Methods: A prospective cohort from the UK Biobank who completed one week of accelerometer-based MVPA measurements from June 1, 2013, to December 23, 2015 was analyzed. The exposures were the different doses of MVPA derived from accelerometry. The main outcomes and measures were the dose-response associations between moderate-to-vigorous MVPA and incident CVD in individuals with and without a family history of CVD.
Results: 74,715 individuals (mean age 55.2 years) were examined. The median follow-up time was 7.9 years. The dose-response association between MVPA and incident CVD among individuals with family history of CVD showed significant risk reductions within the range of 10-1,555 weekly minutes (reference: 0 MVPA minutes). The optimal risk reduction (i.e., nadir of the curve) was identified at 555 weekly minutes of MVPA (HR, 0.72 [95% CI, 0.64-0.81]). The dose-response associations between MVPA and incident CVD among individuals with no family history of CVD showed significant risk reductions within the range of 220-555 weekly minutes. The optimal risk reduction was identified at 445 weekly minutes of MVPA (HR, 0.80 [95% CI, 0.65-0.99]).
Conclusions: Physical activity guidelines should account for familial CVD history, as those with a family history may achieve greater risk reductions.
期刊介绍:
The American Journal of Preventive Medicine is the official journal of the American College of Preventive Medicine and the Association for Prevention Teaching and Research. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health.
Of particular emphasis are papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women''s health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and substance use disorders. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. Papers on health services research pertinent to prevention and public health are also published. The journal also publishes official policy statements from the two co-sponsoring organizations, review articles, media reviews, and editorials. Finally, the journal periodically publishes supplements and special theme issues devoted to areas of current interest to the prevention community.